Free Trial

Fulgent Genetics (FLGT) Earnings Date, Estimates & Call Transcripts

Fulgent Genetics logo
$14.92 +0.02 (+0.13%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$14.92 0.00 (0.00%)
As of 05/6/2026 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Fulgent Genetics Earnings Summary

Fulgent Genetics released Q4 2025 earnings on February 27, 2026, reporting an EPS of $0.16, which topped analysts' consensus estimates of $0.02 by $0.14. Quarterly revenue was reported to be $83.34 million, below the consensus estimate of $85.38 million. With a trailing EPS of -$2.39, Fulgent Genetics' earnings are expected to grow next year, from ($2.48) to ($2.40) per share.

Latest Q4
Earnings Date
Feb. 27Estimated
Consensus EPS
(Feb. 27)
$0.02
Actual EPS
(Feb. 27)
$0.16 Beat By $0.14
Actual Revenue
(Feb. 27)
$83.34M

Q4 2025 Earnings Resources

Get Fulgent Genetics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fulgent Genetics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

FLGT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FLGT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Fulgent Genetics Analyst EPS Estimates

Current Year EPS Consensus Estimate
($2.48) EPS
Next Year EPS Consensus Estimate
($2.40) EPS

Fulgent Genetics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/27/2026Q4 2025$0.02$0.16+$0.14-$0.76$85.38M$83.34M
11/7/2025Q3 2025-$0.2242$0.14+$0.3642-$0.21$81.43M$84.07M
8/1/2025Q2 2025-$0.23$0.07+$0.30-$0.62$76.21M$81.80M
5/2/2025Q1 2025-$0.18$0.04+$0.22-$0.37$71.26M$73.46M
8/2/2024Q2 2024-$0.30$0.15+$0.45-$0.15$69.07M$71.03M

Data powered by Fiscal.ai.

Fulgent Genetics Earnings - Frequently Asked Questions

Fulgent Genetics (NASDAQ:FLGT) last announced its quarterly earning data on Friday, February 27, 2026. Learn more on FLGT's earnings history.

Fulgent Genetics issued an update on its FY 2026 earnings guidance on Friday, May, 1st. The company provided earnings per share guidance of -1.590--1.590 for the period, compared to the consensus EPS estimate of -1.590. The company issued revenue guidance of $350.0 million-$350.0 million, compared to the consensus revenue estimate of $349.4 million.

In the previous quarter, Fulgent Genetics (NASDAQ:FLGT) reported $0.16 earnings per share (EPS) to beat the analysts' consensus estimate of $0.02 by $0.14. Learn more on analysts' earnings estimate vs. FLGT's actual earnings.

The conference call for Fulgent Genetics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Fulgent Genetics' latest earnings report can be read online.
Read Transcript

Fulgent Genetics (NASDAQ:FLGT) has a recorded annual revenue of $322.67 million.

Fulgent Genetics (NASDAQ:FLGT) has a recorded net income of -$60.51 million. FLGT has generated -$2.39 earnings per share over the last four quarters.

Fulgent Genetics' earnings are expected to grow from ($2.48) per share to ($2.40) per share in the next year.


This page (NASDAQ:FLGT) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners